What is the clinical presentation of Fanconi anemia in children?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 9, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Clinical Presentation of Fanconi Anemia in Children

Fanconi anemia in children presents with a highly variable phenotype characterized by congenital anomalies (in approximately 60-75% of cases), progressive bone marrow failure, and short stature, though up to one-third of patients may have no physical anomalies at all. 1

Congenital Anomalies and Physical Features

Skeletal Abnormalities

  • Radial ray defects are the hallmark skeletal finding, including thumb hypoplasia or absence, thumb duplication, absent or hypoplastic radii, and other upper limb malformations 1, 2
  • Short stature is present in approximately 75% of patients, resulting from both skeletal malformations and growth hormone deficiency 1, 3
  • Additional skeletal abnormalities occur in approximately 19% of patients 3

Craniofacial and Neurologic Features

  • Microcephaly is extremely common, present in approximately 93% of patients 3
  • Dysmorphic facial features may be observed 1

Skin Manifestations

  • Abnormal skin pigmentation, particularly café-au-lait spots, occurs in approximately 88% of patients 3
  • These cutaneous findings help differentiate Fanconi anemia from other bone marrow failure syndromes 2

Organ System Involvement

  • Genitourinary malformations occur in approximately 31% of patients 3
  • Ophthalmic abnormalities are present in approximately 74% of patients 3
  • Cardiovascular malformations occur in approximately 11% of patients 3
  • Ear and hearing abnormalities are present in approximately 10% of patients 3
  • Gastrointestinal system abnormalities occur in approximately 6% of patients 3
  • Genital system abnormalities are present in approximately 11% of patients 3

Hematologic Manifestations

Bone Marrow Failure

  • Progressive bone marrow failure develops in more than 95% of patients and is the dominant clinical feature 2
  • The mean age at diagnosis of bone marrow failure is approximately 7 years (range: 1 month to 19.8 years) 3
  • Approximately 40% of patients develop severe bone marrow failure by age 20 years, and 50% by age 50 years 1
  • Thrombocytopenia is typically the first hematologic manifestation, presenting as the initial clinical symptom in approximately 83% of patients 3
  • Progressive cytopenias (low hemoglobin, platelets, and neutrophils) may precede any physical findings 2

Malignancy Risk in Childhood

Hematologic Malignancies

  • Approximately 11% of children with Fanconi anemia develop malignancy during the pediatric period 2
  • Acute myeloid leukemia (AML) accounts for more than 80% of leukemias in Fanconi anemia patients 2
  • The cumulative incidence of AML by age 50 is approximately 10%, while myelodysplastic syndrome (MDS) approaches 50% 1, 2
  • A total of 13% of patients in large cohorts develop malignancy during follow-up (predominantly leukemia) 3

Solid Tumors

  • The cumulative incidence of solid tumors by age 50 is approximately 20-30% 2
  • Head and neck squamous cell carcinoma is the most common solid tumor, with a relative risk of approximately 600-fold compared to the general population 2

Genotype-Specific Severe Phenotypes

FANCD1/BRCA2 Mutations

  • Patients with biallelic FANCD1/BRCA2 mutations have the most severe phenotype, with earlier onset of disease and dramatically increased malignancy risk 2, 4
  • The cumulative incidence of leukemia by age 10 is approximately 80% in these patients 2
  • The cumulative incidence of any malignancy by age 7 exceeds 90% 2
  • These patients present with severe congenital anomalies and require modified chemotherapy and radiation protocols due to extreme sensitivity to DNA-damaging agents 4

Diagnostic Considerations

Key Clinical Clues

  • The combination of radial ray defects, abnormal skin pigmentation, short stature, and progressive cytopenias should immediately prompt consideration of Fanconi anemia 2
  • However, approximately 25-40% of patients have no physical anomalies at presentation, making diagnosis challenging 2
  • Some patients may show atypical features including lack of apparent deformities and negative initial chromosomal breakage tests 5

Confirmatory Testing

  • The gold-standard diagnostic test is chromosomal breakage assessment after exposure to diepoxybutane (DEB) or mitomycin C (MMC), which demonstrates characteristic hypersensitivity 1, 2
  • Genetic testing for FANCA gene mutations and assessment of FANCD2 protein ubiquitination can aid diagnosis in atypical cases 5

Important Pitfall

  • Do not exclude Fanconi anemia based solely on absence of congenital anomalies—up to one-third of patients lack physical findings, and progressive cytopenias may be the only presenting feature 1, 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Clinical Features of Fanconi Anemia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Fanconi anemia: a single center experience of a large cohort.

The Turkish journal of pediatrics, 2019

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.